AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEXICON PHARMACEUTICALS, INC. Director's Dealing 2021

Jan 11, 2021

32814_dirs_2021-01-11_7f8fa4c8-3b34-4509-89bc-6b8f4551de33.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2020-12-31

Reporting Person: Invus Partners, LLC (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4321214	Direct

Footnotes

F1: These securities are directly held by Invus Partners, LLC. Ulys, L.L.C. is the managing member of Invus Partners LLC., and Mr. Raymond Debbane is the sole member of Ulys, L.L.C.